Biomarkers predicting treatment outcome in depression: what is clinically significant?

On responder analyses when a continuous variable is dichotomized and measurement error is present

(2011) Michael Kunz   BIOMETRICAL JOURNAL

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline

(2011) Rudolf Uher et al.   JOURNAL OF AFFECTIVE DISORDERS

Translating biomarkers to clinical practice

(2011) R H Perlis   MOLECULAR PSYCHIATRY

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

(2011) R. Uher et al.   PSYCHOLOGICAL MEDICINE

Genes, Environment, and Individual Differences in Responding to Treatment for Depression

(2011) Rudolf Uher   HARVARD REVIEW OF PSYCHIATRY

Genome-Wide Pharmacogenetics of Antidepressant Response in the GENDEP Project

(2010) Rudolf Uher et al.   AMERICAN JOURNAL OF PSYCHIATRY

Personalized Medicine for Depression: Can We Match Patients With Treatments?

(2010) Gregory E. Simon et al.   AMERICAN JOURNAL OF PSYCHIATRY

Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data

(2010) Konstantinos N. Fountoulakis et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Antidepressant Drug Effects and Depression Severity

(2010) Jay C. Fournier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Genomewide Association Study Points to Multiple Loci That Predict Antidepressant Drug Treatment Outcome in Depression

(2009) Marcus Ising et al.   ARCHIVES OF GENERAL PSYCHIATRY

A Genomewide Association Study of Citalopram Response in Major Depressive Disorder

(2009) Holly A. Garriock et al.   BIOLOGICAL PSYCHIATRY

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

(2009) Rudolf Uher et al.   BRITISH JOURNAL OF PSYCHIATRY

Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk

(2009) David M. Evans et al.   HUMAN MOLECULAR GENETICS

When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study

(2009) Roy H Perlis et al.   NEUROPSYCHOPHARMACOLOGY

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

(2008) Irving Kirsch et al.   PLOS MEDICINE